odometer
发表于 2025-3-21 18:55:38
书目名称Management of Hypertension影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0622517<br><br> <br><br>书目名称Management of Hypertension影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0622517<br><br> <br><br>书目名称Management of Hypertension网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0622517<br><br> <br><br>书目名称Management of Hypertension网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0622517<br><br> <br><br>书目名称Management of Hypertension被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0622517<br><br> <br><br>书目名称Management of Hypertension被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0622517<br><br> <br><br>书目名称Management of Hypertension年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0622517<br><br> <br><br>书目名称Management of Hypertension年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0622517<br><br> <br><br>书目名称Management of Hypertension读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0622517<br><br> <br><br>书目名称Management of Hypertension读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0622517<br><br> <br><br>
碎片
发表于 2025-3-21 20:29:54
Arterial Hypertension: What Is the Optimal Goal of Treatment?, it reviews the MRC,the HDFP,the HOT, the SPRINT, the ACCORD and the HOPE-3 studies, and discusses the suggested optimal BP goals derived from these trials. It also focuses on interesting meta-analyses stratifying the different trials according to the BP levels achieved by active treatment.
团结
发表于 2025-3-22 03:25:59
Comparison Therapies in the Treatment of Hypertension. The ASCOT and ACCOMPLISH Trial because few studies intended by design to compare two or more different combinations. ASCOT and ACCOMPLISH are considered the landmark trials in the comparison of combination therapies and had a great impact on hypertension guidelines and everyday clinical practice.
决定性
发表于 2025-3-22 06:14:06
Advantages and Disadvantages in Clinical Trialstrials are essential in establishing the efficacy of pharmacologic and other interventions, but it may be difficult to make decisions on individual patients since the trials include large numbers of participants.
paroxysm
发表于 2025-3-22 10:07:20
http://reply.papertrans.cn/63/6226/622517/622517_5.png
yohimbine
发表于 2025-3-22 15:38:52
Book 2019one studies. All major hypertension trials have been reviewed in this book in chronological order with extensive discussion of the study population, study design, and outcomes and with a special focus on what knowledge they offered, their strengths and weaknesses, statistical errors, impact on inter
慢慢流出
发表于 2025-3-22 18:59:34
http://reply.papertrans.cn/63/6226/622517/622517_7.png
Commonwealth
发表于 2025-3-23 00:57:29
http://reply.papertrans.cn/63/6226/622517/622517_8.png
CHOKE
发表于 2025-3-23 02:16:40
The Life and the Major Scientific Contributions of Irvine Pageged mosaic theory of hypertension. In this chapter we discuss milestone moments in his life and scientific career, and we aim to offer to young scientists engaged in the cardiovascular field an insight into the personality and abilities of this great man, physician and researcher.
comely
发表于 2025-3-23 07:40:36
http://reply.papertrans.cn/63/6226/622517/622517_10.png